What is BCAB's dilution risk score?

BCAB has a latest available DilutionScore record of 94/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BCAB, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BCAB?

DilutionWatch tracks 25 SEC filing types for BCAB including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BCAB shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BCAB, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BCAB tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BCAB. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BCAB Dilution Risk Score: 94/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

96

💰 Cash Runway

95

📊 Float Risk

95

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 42%

💰 Capital Raise model 75%

• Critical: only 0.2 months cash remaining

• Active shelf registration ($200M, 3071% of market cap)

📉 Score Deterioration model 15%

• Score already CRITICAL (94/100) — events likely imminent

🔔 Track BCAB — Get forecast alerts →

Market Data

Market Cap$6.51M

Shares Outstanding32.32M

Float1.38M

Cash$1.54M

Debt$6.09M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 29.0% shares (2026Q1 vs prior)

35 institutional holders · 17.34M shares

#1 ACORN CAPITAL ADVISORS, LLC 5.41M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 3.30M shares

#3 MILLENNIUM MANAGEMENT LLC 2.76M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest105.4K

Days to Cover4.4

% of Float7.6%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

8-K 8K EVENT 2026-03-23

424B2 ATM 2026-03-20

424B2 ATM 2026-03-13

4 INSIDER TRANSACTION 2026-03-12

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BCAB Dilution Snapshot

BioAtla, Inc. (BCAB) has a DilutionScore of 94/100, rated Critical dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $200.0M.
Recent SEC activity tracked for BCAB: xbrl on 2026-06-30; 8-K on 2026-03-23; 424B2 on 2026-03-20.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.